Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-184.46M
↓ 176% below average
Average (9y)
$-66.77M
Historical baseline
Range
High:$-5.87M
Low:$-184.46M
CAGR
+29.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-184.46M | -22.2% |
| 2023 | $-150.94M | -49.0% |
| 2022 | $-101.32M | -41.6% |
| 2021 | $-71.55M | -41.0% |
| 2020 | $-50.76M | -764.5% |
| 2019 | $-5.87M | +83.3% |
| 2018 | $-35.23M | -21.3% |
| 2017 | $-29.04M | -46.3% |
| 2016 | $-19.85M | -6.4% |
| 2015 | $-18.65M | - |